Full video transcriptClick to expand
Auto-generated transcript of @invitewellnessllc's video. Quoted here for educational fact-check commentary; original creator retains all rights to the video content.
- 0:00Part of the evaluation on whether or not you have a low testosterone or not are two questions
- 0:06Well, there's a lot more
- 0:07But the two questions that I'm talking about have to do with libido and sexual function and there is a difference between
- 0:14libido
- 0:15Which is your desire and sexual function?
- 0:19Which is does it work does it get up?
- 0:21Can you get maintained a direction and climax and the reason why it's important to?
- 0:26Distinguished the difference is because you can actually have a pretty healthy libido
- 0:31You can want it. You can desire it. You can be turned on
- 0:37Mentally because libido is very much a mental process
- 0:40But if it's not working then that means the sexual function is low
- 0:45But libido is okay now with low testosterone
- 0:49It doesn't necessarily mean you have a decrease in sexual function or a decrease in libido
- 0:56Although if you do that means your low testosterone is old news
- 1:01You've had it and you've been living with low testosterone or suboptimal
- 1:07testosterone for a long time
TRT telehealth claims: what the evidence actually supports
Quick answer
The video addresses a real and clinically relevant distinction between hypogonadism-related libido suppression and erectile dysfunction, which have overlapping but distinct pathophysiology. While testosterone deficiency reliably impairs sexual desire through central androgen receptor mechanisms, erectile function is more dependent on vascular integrity and nitric oxide signaling, making it a less reliable standalone marker for low testosterone. Clinicians evaluating suspected hypogonadism should assess both symptom domains independently alongside bioavailable testosterone, gonadotropins, and relevant metabolic risk factors.
Video review standard
Clinical fact-check snapshot
FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.
Evidence signal
Source-backed review
Regulatory reality
Access rules depend on the compound and patient situation
Safety screen
Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.
This page currently connects to 9 source-backed evidence items through visible references or structured citation data.
PubMed evidence trail
Research sources used to frame this page
For TRT telehealth claims: what the evidence actually supports, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.
Cardiovascular Safety of Testosterone-Replacement Therapy
TRAVERSE trial anchor for cardiovascular-safety discussions in appropriately diagnosed men.
PubMed
Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline
Guideline anchor for diagnosis, monitoring, contraindications, and appropriate TRT framing.
PubMed
NAD+ metabolism and its roles in cellular processes during ageing
Core review for NAD+ decline, mitochondrial function, DNA repair, and aging biology.
PubMed
Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women
Human NMN source for metabolic claims while keeping population limits clear.
PubMed
Provider decision path
Use local research to choose a safer review path
Direct answer
TRT telehealth claims: what the evidence actually supports is best used to compare access, oversight, pricing, pharmacy quality, and patient support before starting care.
Evidence check
Directory pages should connect local intent with provider standards, pharmacy transparency, and practical next steps.
Safety check
Provider quality, pharmacy source, prescribing model, and follow-up support can matter as much as the medication name.
Next step
When you are ready, the get-started flow can collect the details needed for a prescription review instead of leaving you to guess.
Claim path
Keep researching this testosterone and trt video claims cluster
Best for searchers turning TRT social claims into a safer lab-backed provider discussion.
Page-specific review note
What this exact clip is really saying
This FormBlends review is specific to "TRT telehealth claims: what the evidence actually supports" from Anastasiya, NP. We read the clip as a TRT social video fact-checks claim about Testosterone, then separate the useful signal from what a short social video cannot prove. The page-specific claim focus is: The video addresses a real and clinically relevant distinction between hypogonadism-related libido suppression and erectile dysfunction, which have overlapping but distinct pathophysiology.
The reason this review is not generic is the source wording and the canonical claim label "trt replying to jon hill want to learn more hit follow button re." In this clip, the useful excerpt is: "Part of the evaluation on whether or not you have a low testosterone or not are two questions Well, there's a lot more But the two questions that I'm talking about have to do with libido and sexual function and there is a difference..." That wording changes the review because it points to Testosterone evidence, safety, and patient-fit context, not a one-size-fits-all protocol.
The source trail for this page is checked against Cardiovascular Safety of Testosterone-Replacement Therapy (2023), Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline (2010), and Functional testosterone deficiency in aging men: Clinical impact, diagnostic pathways, and treatment strategies (2026), plus the creator's own wording. Testosterone decisions still need an eligibility review, medication-interaction screen, access check, and quality-control review before anyone treats a social clip as medical advice.
Claim verdict
The useful answer behind this video
This page is built to answer the specific claim behind the clip, then separate what is useful from what still needs clinical context. That makes the URL more than a repost: it gives Google, readers, and AI retrieval systems a concise verdict with source and safety boundaries.
Claim being checked
The video addresses a real and clinically relevant distinction between hypogonadism-related libido suppression and erectile dysfunction, which have overlapping but distinct pathophysiology.
FormBlends verdict
Testosterone evidence, safety, and patient-fit context
Evidence strength
Source-backed review with clinical or regulatory citations.
Patient-safe next step
Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.
What to do with this video
Use the clip as a claim to verify, not a treatment plan
What it helps with
- The video addresses a real and clinically relevant distinction between hypogonadism-related libido suppression and erectile dysfunction, which have overlapping but distinct pathophysiology. While testosterone deficiency reliably impairs sexual desire through central androgen receptor mechanisms, erectile function is more dependent on vascular integrity and nitric oxide signaling, making it a less reliable standalone marker for low testosterone. Clinicians evaluating suspected hypogonadism should assess both symptom domains independently alongside bioavailable testosterone, gonadotropins, and relevant metabolic risk factors.
- Testosterone has a stronger, more consistent effect on libido than on erectile function, per Bhasin et al. (2010, NEJM) — ED without low desire is more likely vascular or neurological than hormonal.
- A single total testosterone level is not enough: free testosterone, SHBG, LH, and FSH are all needed to accurately assess androgen status in a clinical evaluation.
What it may miss
- It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
- Compound access, legal status, and product quality still need a separate safety check.
- Social video captions rarely show the full evidence base behind a claim.
Best next step
Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.
Start provider reviewWhat You'll Learn
- Testosterone has a stronger, more consistent effect on libido than on erectile function, per Bhasin et al. (2010, NEJM) — ED without low desire is more likely vascular or neurological than hormonal.
- A single total testosterone level is not enough: free testosterone, SHBG, LH, and FSH are all needed to accurately assess androgen status in a clinical evaluation.
- The claim that both low libido and ED together signal long-standing low testosterone is an oversimplification — SSRIs, cardiovascular disease, and diabetes can produce the same picture with normal testosterone levels.
- Wang et al. (2000, Journal of Clinical Endocrinology and Metabolism) found that hypogonadal men most commonly reported reduced libido, while erectile dysfunction was more variable and often required treatment beyond testosterone replacement alone.
- Telling your clinician which symptom you have — desire problem versus performance problem — genuinely changes the differential diagnosis and the appropriate workup, so the creator's point about distinguishing them is practically useful.
- Prolonged androgen deficiency can degrade erectile tissue quality over time, per Traish et al. (2011, Journal of Andrology), but this does not mean symptom severity alone can reliably date how long someone has had low testosterone.
Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team · This is not a transcript. It is our independent review of the video above.
What did @invitewellnessllc actually say?
The creator drew a line between two symptoms that most people lump together: libido (the desire for sex) and sexual function (erections, maintenance, and orgasm). Their core claim is that these are separate systems. They also argued that if a man with low testosterone has both low libido and poor sexual function, "your low testosterone is old news" — meaning the deficiency has been long-standing.
That's a reasonable clinical distinction to make. Libido is largely driven by central nervous system and hormonal inputs, including testosterone, but also dopamine signaling. Erectile function, meanwhile, is more vascular and neurological in nature. A man can want sex and not be able to perform, or perform adequately while showing little interest. These two complaints don't always travel together, and conflating them in a clinical intake form leads to missed diagnoses or misattributed symptoms.
Does the science back this up?
Mostly, yes — but with important nuance that the video skips over. The claim that libido and erectile dysfunction are distinct physiologically is well-supported. Where it gets murkier is the timeline claim about long-standing low testosterone.
Testosterone does play a role in both libido and, to a lesser extent, erectile quality, but erectile dysfunction (ED) is predominantly vascular and neurogenic. A landmark review by Bhasin et al. (2010, New England Journal of Medicine) confirmed that androgen deficiency reliably suppresses sexual desire but has a more inconsistent relationship with erectile function. Men with low testosterone can maintain normal erections, particularly in response to erotic stimuli, because the erectile mechanism depends heavily on nitric oxide pathways and penile vascular health, not testosterone alone.
Studies like Traish et al. (2011, Journal of Andrology) found that prolonged androgen deficiency does eventually impair erectile tissue health, which supports the creator's "old news" claim to a degree. But calling the timeline definitively "long-standing" based solely on the presence of both symptoms is an oversimplification. Other causes, including cardiovascular disease, diabetes, and psychological factors, can produce the same dual-symptom picture in men with completely normal testosterone.
What did they get wrong (or right)?
They got the core distinction right. Libido being "very much a mental process" is a reasonable lay summary of a well-documented reality: desire involves CNS dopamine circuits, hypothalamic signaling, and psychological state, not just circulating testosterone levels.
Where the video oversimplifies is the claim that having both low libido and low sexual function automatically signals that low testosterone is "old news." That framing implies a reliable chronological marker that the evidence doesn't cleanly support. A man could develop both problems simultaneously from a sudden testosterone crash, a medication side effect (SSRIs are notorious for this), or a new cardiovascular event. Assuming symptom co-occurrence equals chronicity is a clinical shortcut that could lead providers and patients to wrong conclusions about how long someone has been undertreated.
There's also no mention of the role of SHBG (sex hormone-binding globulin), which affects how much testosterone is actually bioavailable. Two men with identical total testosterone readings can have very different free testosterone levels and very different symptoms.
What should you actually know?
If you're trying to understand your own symptoms before a TRT evaluation, the libido-versus-function distinction is genuinely useful. Tell your clinician specifically which problem you're experiencing, because the workup and treatment implications differ.
- Low libido with normal erectile function points more strongly toward androgen insufficiency, depression, or relationship factors.
- ED with preserved libido more commonly points toward vascular, neurological, or medication-related causes — and may not respond well to testosterone therapy alone.
- Both together warrants a thorough investigation that goes beyond a single total testosterone draw. Ask about free testosterone, LH, FSH, prolactin, and metabolic markers.
Wang et al. (2000, Journal of Clinical Endocrinology and Metabolism) found that hypogonadal men reported decreased libido as the most common symptom, but ED was more variable and often required treatment beyond TRT. If you're evaluating a telehealth TRT provider, a good one will ask about these separately, not bundle them into a single "sexual symptoms" checkbox.
Interested in GLP-1 or peptide therapy?
Get matched with licensed-provider review to help decide if it is right for you.
About the Creator
Anastasiya, NP · TikTok creator
1.3K views on this video
Replying to @Jon Hill •Want to learn more? Hit follow button. •Ready to get started with a medical evaluation? Book now at InviteWellnessTRT.com •Have a quick question? Send a DM
Frequently asked questions
Quick answers based on this video and our medical team review.
What does the video say about testosterone has a stronger, more consistent effect on libido than?
Testosterone has a stronger, more consistent effect on libido than on erectile function, per Bhasin et al. (2010, NEJM) — ED without low desire is more likely vascular or neurological than hormonal.
What does the video say about a single total testosterone level?
A single total testosterone level is not enough: free testosterone, SHBG, LH, and FSH are all needed to accurately assess androgen status in a clinical evaluation.
What does the video say about the claim?
The claim that both low libido and ED together signal long-standing low testosterone is an oversimplification — SSRIs, cardiovascular disease, and diabetes can produce the same picture with normal testosterone levels.
What does the video say about wang et al. (2000, journal of clinical endocrinology?
Wang et al. (2000, Journal of Clinical Endocrinology and Metabolism) found that hypogonadal men most commonly reported reduced libido, while erectile dysfunction was more variable and often required treatment beyond testosterone replacement alone.
What does the video say about telling your clinician?
Telling your clinician which symptom you have — desire problem versus performance problem — genuinely changes the differential diagnosis and the appropriate workup, so the creator's point about distinguishing them is practically useful.
What does the video say about prolonged?
Prolonged androgen deficiency can degrade erectile tissue quality over time, per Traish et al. (2011, Journal of Andrology), but this does not mean symptom severity alone can reliably date how long someone has had low testosterone.
Sources & references
Citations extracted from our medical team's review. Click any citation to search PubMed.
Not medical advice. This video was made by Anastasiya, NP, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.